In a murine model of B cell lymphoma, CD1d-expressing tumor cells demonstrated increased tumor progression in Jα18 KO mice as compared to CD1d-deficient tumor cells [51]. This evidence concerns the gene CD1D and B-cell non-Hodgkin lymphoma.